Blastomycosis Treatments
Find Blastomycosis Treatments
Generic Name
Ultramicrosize
Brand Names
Grisofulvin, Microsize
FDA approval date: September 09, 1971
Classification: Tubulin Inhibiting Agent
Form: Tablet, Suspension
What is Grisofulvin (Ultramicrosize)?
Ultramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis , tinea pedis , tinea cruris , tinea barbae , tinea capitis , and tinea unguium , when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis,Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audouini, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. NOTE: Prior to therapy, the type of fungi responsible for the infection should be identified. The use of the drug is not justified in minor or trivial infections which will respond to topical agents alone. Griseofulvin is not effective in the following: bacterial infections, candidiasis , histoplasmosis, actinomycosis, sporotrichosis, chromoblastomycosis, coccidioidomycosis, North American blastomycosis, cryptococcosis , tinea versicolor and nocardiosis.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment